4 products were found matching "141505-33-1"!
No results were found for the filter!
Levosimendan
Item number: Cay16128-50
Levosimendan is a calcium sensitizer that can cause increased cardiac contractility by binding troponin C (EC50 = 9 nM), promotes vasodilation by activating ATP-sensitive potassium channels on vascular smooth muscle cells (EC50 = 0.28 µM), and performs a cardioprotective function by prompting the opening of...
| Keywords: | (R)-Simendan, OR 1259, Simdax(R),... |
| Application: | PDE3 inhibitor |
| CAS | 141505-33-1 |
| MW: | 280.3 D |
From 78.00€
*
Levosimendan
Item number: LKT-L1884.250
A Ca(2) sensitizer that increases contractile force of the myocardium by enhancing the sensitivity ofmyofilaments to calcium without increasing intracellular calcium concentration. It has been shown to reduce circulating proinflammatory cytokine interleukin-6 and soluble apoptosis mediators.
| Application: | Ca sensitizer |
| CAS | 141505-33-1 |
| MW: | 280,28 D |
From 198.00€
*
Levosimendan
Item number: TGM-T2530-100mg
Description: Levosimendan (OR1259) is a calcium sensitizer used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing...
| Keywords: | OR1855, OR1259 |
| Application: | Cardiotonic, Phosphodiesterase inhibitor |
| CAS | 141505-33-1 |
| MW: | 280.28 D |
From 31.00€
*
Levosimendan
Item number: LKT-L1884.25
A Ca(2) sensitizer that increases contractile force of the myocardium by enhancing the sensitivity ofmyofilaments to calcium without increasing intracellular calcium concentration. It has been shown to reduce circulating proinflammatory cytokine interleukin-6 and soluble apoptosis mediators.
| Keywords: | Simdax, Mesoxalonitrile (-)-(p((R)-1,4,5,6-tetrahydro-4-methyl-6- oxo-3-pyridazinyl)phenyl)hydrazone |
| Application: | Ca sensitizer |
| CAS | 141505-33-1 |
| MW: | 280.28 D |
94.00€
*
